The application of nano-medicine to overcome the challenges related to immune checkpoint blockades in cancer immunotherapy: Recent advances and opportunities
Author:
Funder
Shahid Beheshti University of Medical Sciences
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference217 articles.
1. Adverse events associated with immune checkpoint blockade in patients with Cancer: a systematic review of case reports;Abdel-Wahab;PLoS One,2016
2. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes;Agata;Int. Immunol.,1996
3. T-cell regulation by CD28 and CTLA-4;Alegre;Nat. Rev. Immunol.,2001
4. PD-1 and PD-L1 checkpoint signaling inhibition for Cancer immunotherapy: mechanism, combinations, and clinical outcome;Alsaab;Front. Pharmacol.,2017
5. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation;Anderson;Immunity,2016
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Advancing Role of Nanocomposites in Cancer Diagnosis and Treatment;International Journal of Nanomedicine;2024-06
2. Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies;Journal of Molecular Graphics and Modelling;2024-05
3. Two effective factors in cancer: Investigating the effect of ncRNAs in cancer and also the effect of nanotherapy in its treatment;Pathology - Research and Practice;2024-04
4. Novel nanomaterials as photo‐activated cancer diagnostics and therapy;Medicine Advances;2023-09
5. Nanoparticles in Medicine: Current Status in Cancer Treatment;International Journal of Molecular Sciences;2023-08-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3